Edlund, Per, Johan Ahlgren, Karsten Bjerre, Michael Andersson, Jonas Bergh, Henning Mouridsen, Stig B. Holmberg, et al. “Dose-Tailoring of FEC Adjuvant Chemotherapy Based on Leukopenia Is Feasible and Well Tolerated. Toxicity and Dose Intensity in the Scandinavian Breast Group Phase 3 Adjuvant Trial SBG 2000-1”. Acta Oncologica 50, no. 3 (April 1, 2011): 329–337. Accessed May 1, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/31961.